Assessment of the Association Between Cardiac Metabolic Markers and Carotid Atherosclerosis, and the Role of Insulin Resistance.

IF 3 3区 医学 Q3 ENDOCRINOLOGY & METABOLISM
Yazhao Sun, Chunlan Bai, Shitong Yin, Jianfeng Liu
{"title":"Assessment of the Association Between Cardiac Metabolic Markers and Carotid Atherosclerosis, and the Role of Insulin Resistance.","authors":"Yazhao Sun, Chunlan Bai, Shitong Yin, Jianfeng Liu","doi":"10.2147/DMSO.S539166","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Obesity is a growing global health concern. The cardiometabolic index (CMI), a novel marker of fat distribution, has been proposed as a potential risk indicator. This study investigates the association between CMI and carotid atherosclerosis (CAS), as assessed by carotid intima-media thickness (cIMT), and explores whether insulin resistance (IR) mediates this relationship.</p><p><strong>Methods: </strong>This cross-sectional study enrolled type 2 diabetes mellitus (T2DM) patients hospitalized at Cangzhou People's Hospital between September 2024 and March 2025. Logistic regression models, restricted cubic spline (RCS) analysis, and subgroup analysis were used to examine the CMI-CAS relationship. The predictive ability of CMI was assessed using receiver operating characteristic (ROC) curves, and its incremental value beyond traditional risk factors was evaluated by integrated discrimination improvement (IDI) and net reclassification improvement (NRI). Mediation analysis assessed the role of IR.</p><p><strong>Results: </strong>After adjustment, higher CMI was significantly associated with increased odds of CAS (OR = 1.48, 95% CI: 1.21-1.81, <i>P</i> < 0.001). RCS analysis showed a nonlinear relationship between CMI and CAS. ROC analysis indicated moderate predictive power (AUC = 0.65, 95% CI: 0.61-0.68). Including CMI improved prediction with an IDI of 0.04 (<i>P</i> < 0.001) and an NRI of 0.26 (<i>P</i> < 0.001). Subgroup analysis revealed a significant interaction with T2DM duration (<i>P</i> = 0.013). Mediation analysis showed that metabolic score for insulin resistance (METS-IR) partially mediated the CMI-CAS relationship, explaining 12.92% of the total effect.</p><p><strong>Conclusion: </strong>Elevated CMI is independently associated with higher risk of CAS in T2DM patients, and insulin resistance partially mediates this relationship. CMI may be a valuable marker for early vascular risk stratification in diabetic populations.</p>","PeriodicalId":11116,"journal":{"name":"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy","volume":"18 ","pages":"2899-2911"},"PeriodicalIF":3.0000,"publicationDate":"2025-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12363553/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/DMSO.S539166","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Obesity is a growing global health concern. The cardiometabolic index (CMI), a novel marker of fat distribution, has been proposed as a potential risk indicator. This study investigates the association between CMI and carotid atherosclerosis (CAS), as assessed by carotid intima-media thickness (cIMT), and explores whether insulin resistance (IR) mediates this relationship.

Methods: This cross-sectional study enrolled type 2 diabetes mellitus (T2DM) patients hospitalized at Cangzhou People's Hospital between September 2024 and March 2025. Logistic regression models, restricted cubic spline (RCS) analysis, and subgroup analysis were used to examine the CMI-CAS relationship. The predictive ability of CMI was assessed using receiver operating characteristic (ROC) curves, and its incremental value beyond traditional risk factors was evaluated by integrated discrimination improvement (IDI) and net reclassification improvement (NRI). Mediation analysis assessed the role of IR.

Results: After adjustment, higher CMI was significantly associated with increased odds of CAS (OR = 1.48, 95% CI: 1.21-1.81, P < 0.001). RCS analysis showed a nonlinear relationship between CMI and CAS. ROC analysis indicated moderate predictive power (AUC = 0.65, 95% CI: 0.61-0.68). Including CMI improved prediction with an IDI of 0.04 (P < 0.001) and an NRI of 0.26 (P < 0.001). Subgroup analysis revealed a significant interaction with T2DM duration (P = 0.013). Mediation analysis showed that metabolic score for insulin resistance (METS-IR) partially mediated the CMI-CAS relationship, explaining 12.92% of the total effect.

Conclusion: Elevated CMI is independently associated with higher risk of CAS in T2DM patients, and insulin resistance partially mediates this relationship. CMI may be a valuable marker for early vascular risk stratification in diabetic populations.

Abstract Image

Abstract Image

Abstract Image

心脏代谢标志物与颈动脉粥样硬化的相关性评估及胰岛素抵抗的作用。
背景:肥胖是一个日益严重的全球健康问题。心脏代谢指数(CMI)是一种新的脂肪分布标记物,已被提出作为潜在的危险指标。本研究通过颈动脉内膜-中膜厚度(cIMT)评估CMI与颈动脉粥样硬化(CAS)之间的关系,并探讨胰岛素抵抗(IR)是否介导了这种关系。方法:本横断面研究纳入2024年9月至2025年3月沧州市人民医院住院的2型糖尿病(T2DM)患者。采用Logistic回归模型、限制性三次样条(RCS)分析和亚组分析对CMI-CAS关系进行检验。采用受试者工作特征(ROC)曲线评价CMI的预测能力,采用综合判别改善(IDI)和净重分类改善(NRI)评价CMI超出传统危险因素的增量值。中介分析评估IR的作用。结果:调整后,较高的CMI与增加的CAS几率显著相关(OR = 1.48, 95% CI: 1.21-1.81, P < 0.001)。RCS分析显示CMI与CAS之间存在非线性关系。ROC分析显示中等预测能力(AUC = 0.65, 95% CI: 0.61-0.68)。纳入CMI可改善预测,IDI为0.04 (P < 0.001), NRI为0.26 (P < 0.001)。亚组分析显示与T2DM病程有显著的相互作用(P = 0.013)。中介分析显示,胰岛素抵抗代谢评分(METS-IR)部分介导了CMI-CAS关系,解释了12.92%的总效应。结论:CMI升高与T2DM患者发生CAS风险升高独立相关,胰岛素抵抗在其中起部分作用。CMI可能是糖尿病人群早期血管危险分层的一个有价值的标志。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Pharmacology, Toxicology and Pharmaceutics-Pharmacology
CiteScore
5.90
自引率
6.10%
发文量
431
审稿时长
16 weeks
期刊介绍: An international, peer-reviewed, open access, online journal. The journal is committed to the rapid publication of the latest laboratory and clinical findings in the fields of diabetes, metabolic syndrome and obesity research. Original research, review, case reports, hypothesis formation, expert opinion and commentaries are all considered for publication.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信